By utilizing our established cell lines and GMP cell bank capacity, CLB can rapidly develop and streamline your program development and commercial timelines.

Our process development capacity is defined and designed to ensure scale up directly from bench scale to final manufacturing. Our 3L and 15L bench scale models are designed to replicate the clinical and commercial scale bioreactors to ensure a robust scale up process.

Applying decades of expertise, we can successfully transfer your existing process, or develop new, highly efficient processes to achieve your production goals.